Skandinaviska Enskilda Banken (SEB)
APRE icon

Skandinaviska Enskilda Banken (SEB)’s Aprea Therapeutics APRE Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-108
Closed -$11K – 1000
2021
Q3 		$11K Hold
108
– – ﹤0.01% 996
2021
Q2 		$11K Hold
108
– – ﹤0.01% 1027
2021
Q1 		$11K Hold
108
– – ﹤0.01% 1099
2020
Q4 		$11K Hold
108
– – ﹤0.01% 1112
2020
Q3 		$52K Buy
+108
New +$60.4K ﹤0.01% 970

Other funds holding APRE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s APRE Position: Q4 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Aprea Therapeutics (APRE) in Q4 2021, closing a stake of 108 shares — an estimated $11K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in APRE in Q3 2020 and held it in 5 quarters. The position peaked at $52K in Q3 2020. 41 funds tracked by Wall St. Rank hold APRE as of Q4 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Aprea Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 108 Aprea Therapeutics shares in Q4 2021, an estimated $11K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Aprea Therapeutics in Q3 2020 and held it in 5 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Aprea Therapeutics position peaked at $52K in Q3 2020.
  • 41 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q4 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2021, filed 10 Feb 2022.